Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia

Journal of Steroid Biochemistry and Molecular Biology

Volumn 164, Issue , 2016, Pages 106-109

  Abulkhair, Omalkhair ^a   Saadeddin, Ahmed ^a   Makram, Olaa ^a   Gasmelseed, Ahmed ^a   Pasha, Tabrez ^a   Shehata, Hussam ^a   Fakhoury, Hana M ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Breast cancer; Saudi Arabia; Triple negative; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; EPIDERMAL GROWTH FACTOR RECEPTOR 2; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; REVIEW; SAUDI ARABIA; TRIPLE NEGATIVE BREAST CANCER; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; VITAMIN D DEFICIENCY;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; SAUDI ARABIA; TRIPLE NEGATIVE BREAST NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84962604860     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.11.003     Document Type: Review

References (26)

1. [1] Grant, W.B., 25-Hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case–control versus nested case–control studies. Anticancer Res. 35 (2015), 1153–1160.
2. [2] Mohr, S.B., Gorham, E.D., Alcaraz, J.E., Kane, C.J., Macera, C.A., Parsons, J.K., Wingard, D.L., Garland, C.F., Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 31 (2011), 2939–2948.
3. [3] Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M.J., Mullie, P., Autier, P., Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 128 (2011), 1414–1424.
4. [4] Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., Brenner, H., Meta-analysis: serum vitamin D and breast cancer risk. Eur. J. Cancer 46 (2010), 2196–2205.
5. [5] Gissel, T., Rejnmark, L., Mosekilde, L., Vestergaard, P., Intake of vitamin D and risk of breast cancer—a meta-analysis. J. Steroid Biochem. Mol. Biol. 111 (2008), 195–199.
6. [6] Autier, P., Boniol, M., Pizot, C., Mullie, P., Vitamin D status and ill health: a systematic review. Lancet. Diabetes Endocrinol. 2 (2014), 76–89.
7. [7] Yao, S., Ambrosone, C.B., Associations between vitamin D deficiency and risk of aggressive breast cancer in African–American women. J. Steroid Biochem. Mol. Biol. 136 (2013), 337–341.
8. [8] Peppone, L.J., Rickles, A.S., Janelsins, M.C., Insalaco, M.R., Skinner, K.A., The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann. Surg. Oncol. 19 (2012), 2590–2599.
9. [9] Tretli, S., Schwartz, G.G., Torjesen, P.A., Robsahm, T.E., Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23 (2012), 363–370.
10. [10] Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., El-Hajj Fuleihan, G., Josse, R.G., Lips, P., Morales-Torres, J., Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20 (2009), 1807–1820.
11. [11] Alfawaz, H., Tamim, H., Alharbi, S., Aljaser, S., Tamimi, W., Vitamin D status among patients visiting a tertiary care center in Riyadh, Saudi Arabia: a retrospective review of 3475 cases. BMC Public Health, 14, 2014, 159.
12. [12] Kanan, R.M., Al Saleh, Y.M., Fakhoury, H.M., Adham, M., Aljaser, S., Tamimi, W., Year-round vitamin D deficiency among Saudi female out-patients. Public Health Nutr. 16 (2013), 544–548.
13. [13] Elsammak, M.Y., Al-Wosaibi, A.A., Al-Howeish, A., Alsaeed, J., Vitamin D deficiency in Saudi Arabs. Horm. Metab. Res. 42 (2010), 364–368.
14. [14] Sedrani, S.H., Elidrissy, A.W., El Arabi, K.M., Sunlight and vitamin D status in normal Saudi subjects. Am. J. Clin. Nutr. 38 (1983), 129–132.
15. [15] Elkum, N., Dermime, S., Ajarim, D., Al-Zahrani, A., Alsayed, A., Tulbah, A., Al Malik, O., Alshabanah, M., Ezzat, A., Al-Tweigeri, T., Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer, 7, 2007, 222.
16. [16] Najjar, H., Easson, A., Age at diagnosis of breast cancer in Arab nations. Int. J. Surg. 8 (2010), 448–452.
17. [17] Elkum, N., Al-Tweigeri, T., Ajarim, D., Al-Zahrani, A., Amer, S.M., Aboussekhra, A., Obesity is a significant risk factor for breast cancer in Arab women. BMC Cancer, 14, 2014, 788.
18. [18] Drincic, A.T., Armas, L.A., Van Diest, E.E., Heaney, R.P., Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 20 (2012), 1444–1448.
19. [19] Lagunova, Z., Porojnicu, A.C., Grant, W.B., Bruland, O., Moan, J.E., Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?. Mol. Nutr. Food Res. 54 (2010), 1127–1133.
20. [20] Yousef, F.M., Jacobs, E.T., Kang, P.T., Hakim, I.A., Going, S., Yousef, J.M., Al-Raddadi, R.M., Kumosani, T.A., Thomson, C.A., Vitamin D status and breast cancer in Saudi Arabian women: case–control study. Am. J. Clin. Nutr. 98 (2013), 105–110.
21. [21] Yao, S., Sucheston, L.E., Millen, A.E., Johnson, C.S., Trump, D.L., Nesline, M.K., Davis, W., Hong, C.C., McCann, S.E., Hwang, H., Kulkarni, S., Edge, S.B., O'Connor, T.L., Ambrosone, C.B., Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case–control and a case-series study. PLoS One, 6, 2011, e17251.
22. [22] LaPorta, E., Welsh, J., Modeling vitamin D actions in triple negative/basal-like breast cancer. J. Steroid Biochem. Mol. Biol. 144:Pt. A (2014), 65–73.
23. [23] Gonzalo, S., Novel roles of 1alpha,25(OH) 2D3 on DNA repair provide new strategies for breast cancer treatment. J. Steroid Biochem. Mol. Biol. 144:Pt. A (2014), 59–64.
24. [24] Grotsky, D.A., Gonzalez-Suarez, I., Novell, A., Neumann, M.A., Yaddanapudi, S.C., Croke, M., Martinez-Alonso, M., Redwood, A.B., Ortega-Martinez, S., Feng, Z., Lerma, E., Ramon y Cajal, T., Zhang, J., Matias-Guiu, X., Dusso, A., Gonzalo, S., BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells. J. Cell Biol. 200 (2013), 187–202.
25. [25] Lopes, N., Carvalho, J., Duraes, C., Sousa, B., Gomes, M., Costa, J.L., Oliveira, C., Paredes, J., Schmitt, F., 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res. 32 (2012), 249–257.
26. [26] Moukayed, M., Grant, W.B., Molecular link between vitamin D and cancer prevention. Nutrients 5 (2013), 3993–4021.